Janux Therapeutics (JANX) stock has gone parabolic: what next?

Janux Therapeutics (NASDAQ: JANX) stock price has gone vertical this year, making it one of the top-performing biotech companies in Wall Street. It jumped to a high of $61 on Monday about 975% above the lowest point in 2023, giving it a market cap of over $2.45 billion.  Analysts are optimistic about Janux Janux Therapeutics […]